Endocrine therapy News (1 article)
|
|
Novartis drug Afinitor® met primary endpoint of Phase III study in women with advanced breast cancer; potential to address significant unmet needTrial stopped early after positive interim results showed everolimus plus exemestane extended time without tumor growth Postmenopausal ER+HER2- metastatic breast cancer patients whose disease has progressed despite initial endocrine therapy need effective new... Published on 5 July 2011, 14:27 |
|
Top Categories
We have launched our peer- reviewed, Open-access journal: Insciences Journal
Recently added
27.11.12
Consequential Life Cycle Assessment of Nitrogen Fertilisers Based on Biomass – a Swedish perspective
08.11.12
From Molecular Hollows to Imprinting Strategies – Mass-Sensitive Devices in Host-Guest Chemistry
26.04.12
CdSe/ZnSe Quantum-Dot Semiconductor Optical Amplifiers
23.03.12
Screen-printed Electrochemical Sensors and Biosensors for Monitoring Metal Pollutants


